SAN MATEO, Calif., Sept. 18, 2012 (GLOBE NEWSWIRE) -- First To File® (FTF), a leading provider of SaaS-based IP management technology, announces today that Argos Therapeutics, a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, has chosen its Electronic File Room (EFR) web-based IP information management technology.
First To File will allow Argos to eliminate large volumes of paper storage, build efficiency and enable secure remote access to documents and correspondence for off-site employees. Also, the Electronic File Room will provide the ability to organize patents according to therapeutic platform, which will help Argos sort and find documents more readily.
Elaine Sale, Chief Patent Counsel at Argos, explains, "First To File is an essential part of Argos' plan to go paperless with our intellectual property documents and correspondence. A rapidly-expanding biopharmaceutical company like ours needed to increase efficiency, free up space occupied by paper documents, and have secure access to work effectively from inside or outside the office. After careful consideration, we chose First To File's web-based Electronic File Room. We are excited about the flexibility the system is going to provide and expect that the efficiency and features will help to maximize our productivity going forward."
First To File CEO James P. Bergeron commented, "We are extremely pleased that Argos Therapeutics has selected our Electronic File Room to streamline and help modernize its IP practice. Our technology is proven to replace paper-intensive operations with increased efficiency by creating an always-available document repository and IP automation tools. With First To File, lawyers and staff can securely access documents, share files, and collaborate on matters easily without a lot of painful training or change."
About First To File
Founded in 2006, First To File (FTF) is a software company based in San Mateo, California specializing in intellectual property information management technology. First To File's products automate the storage, management and analysis of legal documents worldwide, enabling law firms and corporate legal professionals to reduce risk and work more effectively.
FTF's Electronic File Room (EFR) for Patents and Trademarks is a web-based document management and automation solution for IP corporate legal and law firms of all sizes. Used by Fortune 500 companies such as Johnson & Johnson and Unilever as well as top IP law firms, EFR for Patents and Trademarks reduces reliance on paper and transforms the prosecution process by increasing overall visibility, efficiency and quality while significantly reducing costs. For more information, visit www.firsttofile.com or follow us on Twitter @FirstToFile or Facebook at http://www.facebook.com/group.php?gid=101788879272.
The First To File logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=14017
About Argos Therapeutics
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform. Argos´ most advanced product candidate AGS-003 has initiated a Phase 3 study for the treatment of mRCC, and the Company plans to have data from its Phase 2b study of AGS-004 for the treatment of HIV in the second half of 2013. Argos also recently completed a successful Phase 1a study of AGS-009 in patients with lupus.